Macquarie Group LTD Ironwood Pharmaceuticals Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Macquarie Group LTD holds 167,200 shares of IRWD stock, worth $588,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,200

Previous 167,200 -0.0%

Holding current value

$588,544

Previous $1.09 Million 36.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$9.9 - $12.43 $37,521 - $47,109	-3,790 Reduced 2.22%	167,200 $2.07 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $1.99 Million - $2.33 Million	167,200 Added 4411.61%	170,990 $2.23 Million
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $1.2 Million - $1.57 Million	-132,758 Reduced 97.22%	3,790 $42,000
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $91,061 - $122,756	-10,062 Reduced 6.86%	136,548 $1.56 Million
Q3 2020 Nov 13, 2020	SELL	$8.99 - $10.74 $45,687 - $54,580	-5,082 Reduced 3.35%	146,610 $1.32 Million
Q2 2020 Aug 11, 2020	BUY	$9.14 - $11.97 $45,837 - $60,029	5,015 Added 3.42%	151,692 $1.57 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $69,566 - $113,593	8,108 Added 5.85%	146,677 $1.48 Million
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $106,572 - $181,510	12,965 Added 10.32%	138,569 $1.85 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $62,380 - $79,591	7,262 Added 6.14%	125,604 $1.08 Million
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $1.16 Million - $1.53 Million	118,342 New	118,342 $1.3 Million
Q1 2018 May 11, 2018	SELL	$11.13 - $13.63 $658,094 - $805,914	-59,128 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$12.16 - $14.58 $630,800 - $756,337	-51,875 Reduced 46.73%	59,128 $886,000
Q3 2017 Nov 08, 2017	BUY	$12.07 - $14.87 $1.34 Million - $1.65 Million	111,003	111,003 $1.75 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Ironwood Pharmaceuticals Inc Transaction History